Proteogenomic characterization of cervical cancer identifies molecular subtypes predictive of clinical outcomes and subtype-specific targets

Journal:

Journal of Clinical Investigation

Published:

2026-02-10

DOI:

10.1172/jci199497

Affiliations:

12

Authors:

18

Go to article

Institutions	Authors	Share
Central Hospital of Wuhan, China	10.000000 10.000000	0.56
Beijing Proteome Research Center (BPRC), China	1.500000	0.08
National Center for Protein Sciences - Beijing, China	1.500000	0.08
Guilin People's Hospital, China	1.000000	0.06
Beijing Qinglian Biotech Co., Ltd., China	1.000000	0.06
GeneRulor Company Bio-X Lab, China	1.000000	0.06
Women's Hospital, Zhejiang University School of Medicine, China	1.000000	0.06
Wuhan University (WHU), China	0.500000	0.03
Zhongnan Hospital, WHU, China	0.500000	0.03

Interested in Oncology and Carcinogenesis?